Clinical Trial Update: Isolated Thoracic Perfusion (ITP-F) for MPM

View source ↗

Summary

A clinical trial evaluating Isolated Thoracic Perfusion with ITP-F for malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Snippet

Sponsor: Medias Klinikum for Surgical Oncology | Conditions: Mesothelioma | Status: COMPLETED